{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:15:34Z","timestamp":1780528534787,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,3]],"date-time":"2027-04-03T00:00:00Z","timestamp":1806710400000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.parkreldis.2026.108301","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:11:46Z","timestamp":1775059906000},"page":"108301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy, safety and predictors of response to electroconvulsive therapy in Lewy body disease"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1911-9510","authenticated-orcid":false,"given":"Matasaburo","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-1200","authenticated-orcid":false,"given":"Yoshiyuki","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-3162","authenticated-orcid":false,"given":"Yuto","family":"Satake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kanemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8794-6895","authenticated-orcid":false,"given":"Tomotaka","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Kigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Utsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2026.108301_bib1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2026.108301_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson's disease: advances and challenges","volume":"21","author":"Weintraub","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2026.108301_bib3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108301_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes \u2014 key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108301_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108301_bib6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/gps.4433","article-title":"Caregiver burden in family carers of people with dementia with lewy bodies and Alzheimer's disease","volume":"31","author":"Svendsboe","year":"2016","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.parkreldis.2026.108301_bib7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/jamaneurol.2024.0586","article-title":"Progress in pharmacologic management of neuropsychiatric syndromes in neurodegenerative disorders: a review","volume":"81","author":"Cummings","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2026.108301_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2025.104510","article-title":"Electroconvulsive therapy for dementia with Lewy bodies: a systematic review and Japanese multicenter survey","volume":"108","author":"Fujishiro","year":"2025","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.parkreldis.2026.108301_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5498\/wjp.v12.i2.348","article-title":"Catatonia in older adults: a systematic review","volume":"12","author":"Jaimes-Albornoz","year":"2022","journal-title":"World J. Psychiatr."},{"key":"10.1016\/j.parkreldis.2026.108301_bib10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4088\/JCP.v66n0514","article-title":"Neuroleptic sensitivity in parkinson's disease and Parkinsonian dementias","volume":"66","author":"Aarsland","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.parkreldis.2026.108301_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1531-8257(200101)16:1<135::AID-MDS1006>3.0.CO;2-Q","article-title":"The Parkinson study group, Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial","volume":"16","author":"Factor","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108301_bib12","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1212\/01.wnl.0000260060.60870.89","article-title":"Quetiapine for agitation or psychosis in patients with dementia and parkinsonism","volume":"68","author":"Kurlan","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108301_bib13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108301_bib14","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108301_bib15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mds.10482","article-title":"Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3\u2010month observations","volume":"18","author":"Benamer","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108301_bib16","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1007\/s00259-023-06171-x","article-title":"A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice","volume":"50","author":"Chahid","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.parkreldis.2026.108301_bib17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/jnnp-2017-317398","article-title":"123 I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study","volume":"89","author":"Komatsu","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2026.108301_bib18","first-page":"1326","article-title":"Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice?","volume":"17","author":"Stefanelli","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.parkreldis.2026.108301_bib19","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry Edgmont Pa Townsh."},{"key":"10.1016\/j.parkreldis.2026.108301_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/gps.70020","article-title":"Evaluating electroconvulsive therapy for dementia with lewy bodies, including the prodromal stage: a retrospective study on safety and efficacy","volume":"39","author":"Morikawa","year":"2024","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.parkreldis.2026.108301_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/neu.2018.32","article-title":"ECT in schizophrenia: a review of the evidence","volume":"31","author":"Grover","year":"2019","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.parkreldis.2026.108301_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0165-0327(93)90015-C","article-title":"ECT in the treatment of the catatonic syndrome","volume":"29","author":"Rohland","year":"1993","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.parkreldis.2026.108301_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115328","article-title":"Outcome prediction of electroconvulsive therapy for depression","volume":"326","author":"Van Der Does","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.parkreldis.2026.108301_bib24","article-title":"Reduced striatal dopamine transmission as a transdiagnostic substrate of psychomotor retardation","author":"Leong","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2026.108301_bib25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamapsychiatry.2025.1811","article-title":"Dopamine and mood in psychotic disorders: An18 F-DOPA PET study","volume":"82","author":"Jauhar","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.parkreldis.2026.108301_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/npp.2010.182","article-title":"Electroconvulsive therapy alters dopamine signaling in the striatum of non-human Primates","volume":"36","author":"Landau","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.parkreldis.2026.108301_bib27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1152\/jn.00740.2016","article-title":"Rapid and lasting enhancement of dopaminergic modulation at the hippocampal mossy fiber synapse by electroconvulsive treatment","volume":"117","author":"Kobayashi","year":"2017","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.parkreldis.2026.108301_bib28","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00702-023-02669-8","article-title":"Depression in dementia with Lewy bodies: a critical update","volume":"130","author":"Jellinger","year":"2023","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2026.108301_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jnnp-2020-324266","article-title":"Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson's disease: a cross-sectional study","volume":"92","author":"Kazmi","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2026.108301_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2023-333007","article-title":"Neuroanatomical and prognostic associations of depression in Parkinson's disease","author":"Badenoch","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2026.108301_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.osep.2024.10.003","article-title":"Characteristics of severe late-life depression in the prodromal phase of neurodegenerative dementia","volume":"5","author":"Nishida","year":"2025","journal-title":"Am. J. Geriatr. Psychiatry Open Sci. Educ. Pract."},{"key":"10.1016\/j.parkreldis.2026.108301_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/YCT.0000000000000809","article-title":"Ultrabrief right unilateral electroconvulsive therapy for the treatment of the neuropsychiatric symptoms of dementia with lewy bodies","volume":"38","author":"Hermida","year":"2022","journal-title":"J. ECT"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026001288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026001288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:33:18Z","timestamp":1778815998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026001288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":32,"alternative-id":["S1353802026001288"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108301","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety and predictors of response to electroconvulsive therapy in Lewy body disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108301"}}